The Wider Considerations in Translating Heart Failure Guidelines.

Congestive Heart Failure (CHF) is as an emerging epidemic. Within one generation the medical community has learnt much of the CHF syndrome. It has two distinct mechanisms, systolic and diastolic abnormalities, to account for the common CHF presentation. It is complex as it challenges the available health care services, resource, and funding models in providing an equitable service across the health continuum. Despite improvement in many cardiovascular diseases, some CHF outcomes like readmissions and costs have increased. The reinvigoration of evidence-based medicine, development of health services models of care, standardisation of disease processes with taxonomies have also occurred within the same time span. These processes however need to be linked with health policy as presented in white papers. In this paper we explore achieving optimal CHF guideline recommended outcomes as the science approaches real world translation.